CARDEAS PHARMA Corp — Form D/A
CARDEAS PHARMA Corp of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2015-04-09. The offering totals $37.5M, of which $37.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-04-09
- Form: D/A
- Accession: 0001168404-15-000010
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $37.5M
- Amount sold: $37.5M
- Investors: 21
- Date of first sale: 2013-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-196992
Issuer
- Name: CARDEAS PHARMA Corp
- CIK: 0001497414
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 2025 1ST AVENUE, SEATTLE, WA, 98121
- Phone: 206-973-1026
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Aaron Bruce Davidson | Director | Seattle, WA |
| Robert Bruce deGavre | Director | Seattle, WA |
| Kevin Bruce Kinsella | Director | Seattle, WA |
| Peter Bruce Moldt | Director | Seattle, WA |
| A. Bruce Montgomery | Director | Seattle, WA |
| Anthony Bruce Scullion | Director | Seattle, WA |
| A. Bruce Montgomery | Executive Officer | Seattle, WA |
| Melissa Yeager | Executive Officer | Seattle, WA |
| A. Bruce Montgomery | Promoter | Seattle, WA |
| Melissa Yeager | Promoter | Seattle, WA |
| Melissa Yeager | Director | Seattle, WA |
| Stephen Bruce Graham | Executive Officer | Seattle, WA |
Other filings by this issuer (6)
More